Your browser doesn't support javascript.
loading
Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria.
Giannone, Fabio; Capretti, Giovanni; Abu Hilal, Mohammed; Boggi, Ugo; Campra, Donata; Cappelli, Carla; Casadei, Riccardo; De Luca, Raffaele; Falconi, Massimo; Giannotti, Gabriele; Gianotti, Luca; Girelli, Roberto; Gollini, Paola; Ippolito, Davide; Limerutti, Giorgio; Maganuco, Lorenzo; Malagnino, Valeria; Malleo, Giuseppe; Morone, Mario; Mosconi, Cristina; Mrakic, Federica; Palumbo, Diego; Salvia, Roberto; Sgroi, Salvatore; Zerbi, Alessandro; Balzano, Gianpaolo.
Afiliação
  • Giannone F; From the Division of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Capretti G; Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
  • Abu Hilal M; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Boggi U; Department of Surgery, Hepato-pancreato-biliary Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Campra D; Department of Surgery, HPB Unit, Southampton University Hospital, Southampton, United Kingdom.
  • Cappelli C; Department of Surgery, University of Pisa and Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Casadei R; General Surgery and Emergency Department, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • De Luca R; Department of Radiology, University of Pisa and Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Falconi M; Division of Pancreatic Surgery, IRCCS, Azienda Ospedaliero Universitaria di Bologna and Department of Internal Medicine and Surgery, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Giannotti G; Department of Surgical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
  • Gianotti L; From the Division of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Girelli R; Vita-Salute San Raffaele University, Milan, Italy.
  • Gollini P; Department of Radiology, University of Verona Hospital Trust, Verona, Italy.
  • Ippolito D; School of Medicine and Surgery, Milano-Bicocca University and Department of Surgery, San Gerardo Hospital, Monza, Italy.
  • Limerutti G; Pancreatic Surgery Unit, "P. Pederzoli" Hospital, Peschiera del Garda, Verona, Italy.
  • Maganuco L; Radiology and Neuroradiology Unit, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy.
  • Malagnino V; Department of Radiology, San Gerardo Hospital, Monza, Italy.
  • Malleo G; Department of Radiology 2, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Morone M; General Surgery Unit 2 and Pancreas Group, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy.
  • Mosconi C; Department of Radiology, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
  • Mrakic F; The Pancreas Institute, Department of General and Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
  • Palumbo D; Department of Radiology, Fondazione Poliambulanza, Brescia, Italy.
  • Salvia R; Department of Radiology, Policlinico "S. Orsola Malpighi," Bologna, Italy.
  • Sgroi S; Department of Radiology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
  • Zerbi A; Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Balzano G; The Pancreas Institute, Department of General and Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
Ann Surg Open ; 2(3): e087, 2021 Sep.
Article em En | MEDLINE | ID: mdl-37635813
Objectives: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. Background: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. Methods: Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss' k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or <60 resections/year) were assessed. Results: Complete agreement among 22 observers was recorded in 5 CT scans (7.2%), whereas 25 CT scans (36.2%) were variously assigned to all 3 resectability classes. Interobserver agreement varied from fair to moderate (Fleiss' k range: 0.282-0.555), with the lowest agreement for borderline resectable tumors. Assessing vascular contact ≤180° had the lowest agreement for all vessels (k range: 0.196-0.362). The highest concordance was recorded for venous invasion >180° (k range: 0.619-0.756). Neither reviewers' specialty nor hospital volume influenced the agreement. Conclusions: There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article